Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METRICATION: Metoprolol and RIC in Anterior STEMI
NCT03579914Completed
- Sponsor
- Harbin Medical University
- Start
- Nov 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of metoprolol in ST elevation myocardial infarction (STEMI) (4 arms), sponsored by Harbin Medical University. Primary endpoint: Myocardial infarct size at 60 hours. Started Nov 2017; status: completed.
02
Drugs
metoprolol
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03579914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03579914.